Iris pharma

Some people are missing the colored portion of the eye, iris that can be caused by a birth defector tissue-thin iris can be damaged later by an accident or injury so, an artificial iris invented, which can improve quality of life and cosmetic appearance. The artificial iris is flexible and it can fit through a small incision and it is hand-painted to have a very natural appearance.

Iris Pharma specializes in offering preclinical and clinical ophthalmology research services worldwide. Contract research organization (CRO) dedicated to ophthalmology, Iris Pharma helps clients to navigate every stage of the drug and medical device development process like in vivo ocular efficacy studies, Good Laboratory Practice (GLP) preclinical studies, bioanalysis, clinical trials, and marketing surveys.Iris Pharmabring nearly 70 ocular drugs and medical devices to market in the past 27 years, and offers consulting services that help clients to determine the best indication for molecules and products in development.

    Related Conference of Iris pharma

    March 18-19, 2024

    5th World Congress on Ophthalmology and Vision Science

    Zurich, Switzerland
    April 25-26, 2024

    24th Global Ophthalmologists Annual Meeting

    London, UK
    May 09-10, 2024

    7th International Eye and Vision Congress

    Barcelona, Spain
    May 16-17, 2024

    8th World Congress on Eye and Vision

    Rome, Italy
    June 13-14, 2024

    9th International Conference on Eye and Vision

    Barcelona, Spain
    October 10-11, 2024

    34th World Congress on Ophthalmology and Optometry

    Madrid, Spain
    October 10-11, 2024

    10th Global Ophthalmology Meeting

    Madrid, Spain

    Iris pharma Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in